世界のオピオイド誘発性便秘薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Opioid Induced Constipation Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4279 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、オピオイド誘発性便秘薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ルビプロストン、臭化メチルナルトレキソン、ナルデメジン、アルビモパン、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・オピオイド誘発性便秘薬の市場動向 ・企業の競争状況、市場シェア ・オピオイド誘発性便秘薬の種類別市場規模（ルビプロストン、臭化メチルナルトレキソン、ナルデメジン、アルビモパン、その他） ・オピオイド誘発性便秘薬の用途別市場規模（病院薬局、ドラッグストア、オンライン薬局） ・オピオイド誘発性便秘薬の北米市場規模2016-2027（アメリカ、カナダ） ・オピオイド誘発性便秘薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・オピオイド誘発性便秘薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・オピオイド誘発性便秘薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・オピオイド誘発性便秘薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Ironwood Pharmaceuticals Inc、Daiichi Sankyo Co Ltd、Pfizer、Progenics Pharmaceuticals Inc、Shionogi & Co., Ltd、Allergan Plc、Nektar Therapeutics、Purdue Pharma、S.L.A. Pharma AG、Mundipharma International Limited、Ono Pharmaceutical Co., Ltd、Takeda Pharmaceutical Company Limited、Theravance Biopharma Inc、Bausch Health、Cosmo Pharmaceuticals SA、Daewoong Pharmaceutical、C.B. Fleet Company、Sucampo Pharmaceuticals） ・結論

Market Analysis and Insights: Global Opioid Induced Constipation Drugs Market
The global Opioid Induced Constipation Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Opioid Induced Constipation Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Opioid Induced Constipation Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Opioid Induced Constipation Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Opioid Induced Constipation Drugs market.

Global Opioid Induced Constipation Drugs Scope and Market Size
Opioid Induced Constipation Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Induced Constipation Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Other
1.3 Market by Application
1.3.1 Global Opioid Induced Constipation Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Opioid Induced Constipation Drugs Market Perspective (2016-2027)
2.2 Opioid Induced Constipation Drugs Growth Trends by Regions
2.2.1 Opioid Induced Constipation Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Opioid Induced Constipation Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Opioid Induced Constipation Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Opioid Induced Constipation Drugs Industry Dynamic
2.3.1 Opioid Induced Constipation Drugs Market Trends
2.3.2 Opioid Induced Constipation Drugs Market Drivers
2.3.3 Opioid Induced Constipation Drugs Market Challenges
2.3.4 Opioid Induced Constipation Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Opioid Induced Constipation Drugs Players by Revenue
3.1.1 Global Top Opioid Induced Constipation Drugs Players by Revenue (2016-2021)
3.1.2 Global Opioid Induced Constipation Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Opioid Induced Constipation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Opioid Induced Constipation Drugs Revenue
3.4 Global Opioid Induced Constipation Drugs Market Concentration Ratio
3.4.1 Global Opioid Induced Constipation Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Induced Constipation Drugs Revenue in 2020
3.5 Opioid Induced Constipation Drugs Key Players Head office and Area Served
3.6 Key Players Opioid Induced Constipation Drugs Product Solution and Service
3.7 Date of Enter into Opioid Induced Constipation Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid Induced Constipation Drugs Breakdown Data by Type
4.1 Global Opioid Induced Constipation Drugs Historic Market Size by Type (2016-2021)
4.2 Global Opioid Induced Constipation Drugs Forecasted Market Size by Type (2022-2027)

5 Opioid Induced Constipation Drugs Breakdown Data by Application
5.1 Global Opioid Induced Constipation Drugs Historic Market Size by Application (2016-2021)
5.2 Global Opioid Induced Constipation Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Opioid Induced Constipation Drugs Market Size (2016-2027)
6.2 North America Opioid Induced Constipation Drugs Market Size by Type
6.2.1 North America Opioid Induced Constipation Drugs Market Size by Type (2016-2021)
6.2.2 North America Opioid Induced Constipation Drugs Market Size by Type (2022-2027)
6.2.3 North America Opioid Induced Constipation Drugs Market Size by Type (2016-2027)
6.3 North America Opioid Induced Constipation Drugs Market Size by Application
6.3.1 North America Opioid Induced Constipation Drugs Market Size by Application (2016-2021)
6.3.2 North America Opioid Induced Constipation Drugs Market Size by Application (2022-2027)
6.3.3 North America Opioid Induced Constipation Drugs Market Size by Application (2016-2027)
6.4 North America Opioid Induced Constipation Drugs Market Size by Country
6.4.1 North America Opioid Induced Constipation Drugs Market Size by Country (2016-2021)
6.4.2 North America Opioid Induced Constipation Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Opioid Induced Constipation Drugs Market Size (2016-2027)
7.2 Europe Opioid Induced Constipation Drugs Market Size by Type
7.2.1 Europe Opioid Induced Constipation Drugs Market Size by Type (2016-2021)
7.2.2 Europe Opioid Induced Constipation Drugs Market Size by Type (2022-2027)
7.2.3 Europe Opioid Induced Constipation Drugs Market Size by Type (2016-2027)
7.3 Europe Opioid Induced Constipation Drugs Market Size by Application
7.3.1 Europe Opioid Induced Constipation Drugs Market Size by Application (2016-2021)
7.3.2 Europe Opioid Induced Constipation Drugs Market Size by Application (2022-2027)
7.3.3 Europe Opioid Induced Constipation Drugs Market Size by Application (2016-2027)
7.4 Europe Opioid Induced Constipation Drugs Market Size by Country
7.4.1 Europe Opioid Induced Constipation Drugs Market Size by Country (2016-2021)
7.4.2 Europe Opioid Induced Constipation Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Opioid Induced Constipation Drugs Market Size (2016-2027)
8.2 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Type
8.2.1 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Application
8.3.1 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Region
8.4.1 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Opioid Induced Constipation Drugs Market Size (2016-2027)
9.2 Latin America Opioid Induced Constipation Drugs Market Size by Type
9.2.1 Latin America Opioid Induced Constipation Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Opioid Induced Constipation Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Opioid Induced Constipation Drugs Market Size by Type (2016-2027)
9.3 Latin America Opioid Induced Constipation Drugs Market Size by Application
9.3.1 Latin America Opioid Induced Constipation Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Opioid Induced Constipation Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Opioid Induced Constipation Drugs Market Size by Application (2016-2027)
9.4 Latin America Opioid Induced Constipation Drugs Market Size by Country
9.4.1 Latin America Opioid Induced Constipation Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Opioid Induced Constipation Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Opioid Induced Constipation Drugs Market Size (2016-2027)
10.2 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Type
10.2.1 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Application
10.3.1 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Country
10.4.1 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Ironwood Pharmaceuticals Inc
11.1.1 Ironwood Pharmaceuticals Inc Company Details
11.1.2 Ironwood Pharmaceuticals Inc Business Overview
11.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Introduction
11.1.4 Ironwood Pharmaceuticals Inc Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.1.5 Ironwood Pharmaceuticals Inc Recent Development
11.2 Daiichi Sankyo Co Ltd
11.2.1 Daiichi Sankyo Co Ltd Company Details
11.2.2 Daiichi Sankyo Co Ltd Business Overview
11.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Introduction
11.2.4 Daiichi Sankyo Co Ltd Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.2.5 Daiichi Sankyo Co Ltd Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Opioid Induced Constipation Drugs Introduction
11.3.4 Pfizer Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Progenics Pharmaceuticals Inc
11.4.1 Progenics Pharmaceuticals Inc Company Details
11.4.2 Progenics Pharmaceuticals Inc Business Overview
11.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Introduction
11.4.4 Progenics Pharmaceuticals Inc Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.4.5 Progenics Pharmaceuticals Inc Recent Development
11.5 Shionogi & Co., Ltd
11.5.1 Shionogi & Co., Ltd Company Details
11.5.2 Shionogi & Co., Ltd Business Overview
11.5.3 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Introduction
11.5.4 Shionogi & Co., Ltd Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.5.5 Shionogi & Co., Ltd Recent Development
11.6 Allergan Plc
11.6.1 Allergan Plc Company Details
11.6.2 Allergan Plc Business Overview
11.6.3 Allergan Plc Opioid Induced Constipation Drugs Introduction
11.6.4 Allergan Plc Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.6.5 Allergan Plc Recent Development
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Details
11.7.2 Nektar Therapeutics Business Overview
11.7.3 Nektar Therapeutics Opioid Induced Constipation Drugs Introduction
11.7.4 Nektar Therapeutics Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.7.5 Nektar Therapeutics Recent Development
11.8 Purdue Pharma
11.8.1 Purdue Pharma Company Details
11.8.2 Purdue Pharma Business Overview
11.8.3 Purdue Pharma Opioid Induced Constipation Drugs Introduction
11.8.4 Purdue Pharma Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.8.5 Purdue Pharma Recent Development
11.9 S.L.A. Pharma AG
11.9.1 S.L.A. Pharma AG Company Details
11.9.2 S.L.A. Pharma AG Business Overview
11.9.3 S.L.A. Pharma AG Opioid Induced Constipation Drugs Introduction
11.9.4 S.L.A. Pharma AG Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.9.5 S.L.A. Pharma AG Recent Development
11.10 Mundipharma International Limited
11.10.1 Mundipharma International Limited Company Details
11.10.2 Mundipharma International Limited Business Overview
11.10.3 Mundipharma International Limited Opioid Induced Constipation Drugs Introduction
11.10.4 Mundipharma International Limited Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.10.5 Mundipharma International Limited Recent Development
11.11 Ono Pharmaceutical Co., Ltd
11.11.1 Ono Pharmaceutical Co., Ltd Company Details
11.11.2 Ono Pharmaceutical Co., Ltd Business Overview
11.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Introduction
11.11.4 Ono Pharmaceutical Co., Ltd Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.11.5 Ono Pharmaceutical Co., Ltd Recent Development
11.12 Takeda Pharmaceutical Company Limited
11.12.1 Takeda Pharmaceutical Company Limited Company Details
11.12.2 Takeda Pharmaceutical Company Limited Business Overview
11.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Introduction
11.12.4 Takeda Pharmaceutical Company Limited Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.12.5 Takeda Pharmaceutical Company Limited Recent Development
11.13 Theravance Biopharma Inc
11.13.1 Theravance Biopharma Inc Company Details
11.13.2 Theravance Biopharma Inc Business Overview
11.13.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Introduction
11.13.4 Theravance Biopharma Inc Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.13.5 Theravance Biopharma Inc Recent Development
11.14 Bausch Health
11.14.1 Bausch Health Company Details
11.14.2 Bausch Health Business Overview
11.14.3 Bausch Health Opioid Induced Constipation Drugs Introduction
11.14.4 Bausch Health Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.14.5 Bausch Health Recent Development
11.15 Cosmo Pharmaceuticals SA
11.15.1 Cosmo Pharmaceuticals SA Company Details
11.15.2 Cosmo Pharmaceuticals SA Business Overview
11.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Introduction
11.15.4 Cosmo Pharmaceuticals SA Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.15.5 Cosmo Pharmaceuticals SA Recent Development
11.16 Daewoong Pharmaceutical
11.16.1 Daewoong Pharmaceutical Company Details
11.16.2 Daewoong Pharmaceutical Business Overview
11.16.3 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Introduction
11.16.4 Daewoong Pharmaceutical Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.16.5 Daewoong Pharmaceutical Recent Development
11.17 C.B. Fleet Company
11.17.1 C.B. Fleet Company Company Details
11.17.2 C.B. Fleet Company Business Overview
11.17.3 C.B. Fleet Company Opioid Induced Constipation Drugs Introduction
11.17.4 C.B. Fleet Company Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.17.5 C.B. Fleet Company Recent Development
11.18 Sucampo Pharmaceuticals
11.18.1 Sucampo Pharmaceuticals Company Details
11.18.2 Sucampo Pharmaceuticals Business Overview
11.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Introduction
11.18.4 Sucampo Pharmaceuticals Revenue in Opioid Induced Constipation Drugs Business (2016-2021)
11.18.5 Sucampo Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Opioid Induced Constipation Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Lubiprostone
Table 3. Key Players of Methyl Naltrexone Bromide
Table 4. Key Players of Naldemedine
Table 5. Key Players of Alvimopan
Table 6. Key Players of Other
Table 7. Global Opioid Induced Constipation Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Opioid Induced Constipation Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Opioid Induced Constipation Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Opioid Induced Constipation Drugs Market Share by Regions (2016-2021)
Table 11. Global Opioid Induced Constipation Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Opioid Induced Constipation Drugs Market Share by Regions (2022-2027)
Table 13. Opioid Induced Constipation Drugs Market Trends
Table 14. Opioid Induced Constipation Drugs Market Drivers
Table 15. Opioid Induced Constipation Drugs Market Challenges
Table 16. Opioid Induced Constipation Drugs Market Restraints
Table 17. Global Opioid Induced Constipation Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Opioid Induced Constipation Drugs Market Share by Players (2016-2021)
Table 19. Global Top Opioid Induced Constipation Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation Drugs as of 2020)
Table 20. Ranking of Global Top Opioid Induced Constipation Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Opioid Induced Constipation Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Opioid Induced Constipation Drugs Product Solution and Service
Table 24. Date of Enter into Opioid Induced Constipation Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Opioid Induced Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Opioid Induced Constipation Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Opioid Induced Constipation Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Opioid Induced Constipation Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Opioid Induced Constipation Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Opioid Induced Constipation Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Opioid Induced Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Opioid Induced Constipation Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Opioid Induced Constipation Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Opioid Induced Constipation Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Opioid Induced Constipation Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Opioid Induced Constipation Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Opioid Induced Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Opioid Induced Constipation Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Opioid Induced Constipation Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Opioid Induced Constipation Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Opioid Induced Constipation Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Opioid Induced Constipation Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Opioid Induced Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Opioid Induced Constipation Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Opioid Induced Constipation Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Opioid Induced Constipation Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Opioid Induced Constipation Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Opioid Induced Constipation Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Opioid Induced Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Opioid Induced Constipation Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Opioid Induced Constipation Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Opioid Induced Constipation Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Opioid Induced Constipation Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Opioid Induced Constipation Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Opioid Induced Constipation Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Opioid Induced Constipation Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Opioid Induced Constipation Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Opioid Induced Constipation Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Opioid Induced Constipation Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Opioid Induced Constipation Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Ironwood Pharmaceuticals Inc Company Details
Table 65. Ironwood Pharmaceuticals Inc Business Overview
Table 66. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product
Table 67. Ironwood Pharmaceuticals Inc Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 68. Ironwood Pharmaceuticals Inc Recent Development
Table 69. Daiichi Sankyo Co Ltd Company Details
Table 70. Daiichi Sankyo Co Ltd Business Overview
Table 71. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product
Table 72. Daiichi Sankyo Co Ltd Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 73. Daiichi Sankyo Co Ltd Recent Development
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Opioid Induced Constipation Drugs Product
Table 77. Pfizer Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Progenics Pharmaceuticals Inc Company Details
Table 80. Progenics Pharmaceuticals Inc Business Overview
Table 81. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product
Table 82. Progenics Pharmaceuticals Inc Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 83. Progenics Pharmaceuticals Inc Recent Development
Table 84. Shionogi & Co., Ltd Company Details
Table 85. Shionogi & Co., Ltd Business Overview
Table 86. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Product
Table 87. Shionogi & Co., Ltd Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 88. Shionogi & Co., Ltd Recent Development
Table 89. Allergan Plc Company Details
Table 90. Allergan Plc Business Overview
Table 91. Allergan Plc Opioid Induced Constipation Drugs Product
Table 92. Allergan Plc Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 93. Allergan Plc Recent Development
Table 94. Nektar Therapeutics Company Details
Table 95. Nektar Therapeutics Business Overview
Table 96. Nektar Therapeutics Opioid Induced Constipation Drugs Product
Table 97. Nektar Therapeutics Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 98. Nektar Therapeutics Recent Development
Table 99. Purdue Pharma Company Details
Table 100. Purdue Pharma Business Overview
Table 101. Purdue Pharma Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 102. Purdue Pharma Recent Development
Table 103. S.L.A. Pharma AG Company Details
Table 104. S.L.A. Pharma AG Business Overview
Table 105. S.L.A. Pharma AG Opioid Induced Constipation Drugs Product
Table 106. S.L.A. Pharma AG Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 107. S.L.A. Pharma AG Recent Development
Table 108. Mundipharma International Limited Company Details
Table 109. Mundipharma International Limited Business Overview
Table 110. Mundipharma International Limited Opioid Induced Constipation Drugs Product
Table 111. Mundipharma International Limited Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 112. Mundipharma International Limited Recent Development
Table 113. Ono Pharmaceutical Co., Ltd Company Details
Table 114. Ono Pharmaceutical Co., Ltd Business Overview
Table 115. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product
Table 116. Ono Pharmaceutical Co., Ltd Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 117. Ono Pharmaceutical Co., Ltd Recent Development
Table 118. Takeda Pharmaceutical Company Limited Company Details
Table 119. Takeda Pharmaceutical Company Limited Business Overview
Table 120. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product
Table 121. Takeda Pharmaceutical Company Limited Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 122. Takeda Pharmaceutical Company Limited Recent Development
Table 123. Theravance Biopharma Inc Company Details
Table 124. Theravance Biopharma Inc Business Overview
Table 125. Theravance Biopharma Inc Opioid Induced Constipation Drugs Product
Table 126. Theravance Biopharma Inc Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 127. Theravance Biopharma Inc Recent Development
Table 128. Bausch Health Company Details
Table 129. Bausch Health Business Overview
Table 130. Bausch Health Opioid Induced Constipation Drugs Product
Table 131. Bausch Health Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 132. Bausch Health Recent Development
Table 133. Cosmo Pharmaceuticals SA Company Details
Table 134. Cosmo Pharmaceuticals SA Business Overview
Table 135. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product
Table 136. Cosmo Pharmaceuticals SA Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 137. Cosmo Pharmaceuticals SA Recent Development
Table 138. Daewoong Pharmaceutical Company Details
Table 139. Daewoong Pharmaceutical Business Overview
Table 140. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product
Table 141. Daewoong Pharmaceutical Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 142. Daewoong Pharmaceutical Recent Development
Table 143. C.B. Fleet Company Company Details
Table 144. C.B. Fleet Company Business Overview
Table 145. C.B. Fleet Company Opioid Induced Constipation Drugs Product
Table 146. C.B. Fleet Company Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 147. C.B. Fleet Company Recent Development
Table 148. Sucampo Pharmaceuticals Company Details
Table 149. Sucampo Pharmaceuticals Business Overview
Table 150. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product
Table 151. Sucampo Pharmaceuticals Revenue in Opioid Induced Constipation Drugs Business (2016-2021) & (US$ Million)
Table 152. Sucampo Pharmaceuticals Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Induced Constipation Drugs Market Share by Type: 2020 VS 2027
Figure 2. Lubiprostone Features
Figure 3. Methyl Naltrexone Bromide Features
Figure 4. Naldemedine Features
Figure 5. Alvimopan Features
Figure 6. Other Features
Figure 7. Global Opioid Induced Constipation Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Opioid Induced Constipation Drugs Report Years Considered
Figure 12. Global Opioid Induced Constipation Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Opioid Induced Constipation Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Opioid Induced Constipation Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global Opioid Induced Constipation Drugs Market Share by Regions (2022-2027)
Figure 16. Global Opioid Induced Constipation Drugs Market Share by Players in 2020
Figure 17. Global Top Opioid Induced Constipation Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Opioid Induced Constipation Drugs Revenue in 2020
Figure 19. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Opioid Induced Constipation Drugs Market Share by Type (2016-2027)
Figure 23. North America Opioid Induced Constipation Drugs Market Share by Application (2016-2027)
Figure 24. North America Opioid Induced Constipation Drugs Market Share by Country (2016-2027)
Figure 25. United States Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Opioid Induced Constipation Drugs Market Share by Type (2016-2027)
Figure 29. Europe Opioid Induced Constipation Drugs Market Share by Application (2016-2027)
Figure 30. Europe Opioid Induced Constipation Drugs Market Share by Country (2016-2027)
Figure 31. Germany Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Opioid Induced Constipation Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Opioid Induced Constipation Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Opioid Induced Constipation Drugs Market Share by Region (2016-2027)
Figure 41. China Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Opioid Induced Constipation Drugs Market Share by Type (2016-2027)
Figure 49. Latin America Opioid Induced Constipation Drugs Market Share by Application (2016-2027)
Figure 50. Latin America Opioid Induced Constipation Drugs Market Share by Country (2016-2027)
Figure 51. Mexico Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Opioid Induced Constipation Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Opioid Induced Constipation Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Opioid Induced Constipation Drugs Market Share by Country (2016-2027)
Figure 57. Turkey Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Opioid Induced Constipation Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Ironwood Pharmaceuticals Inc Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 61. Daiichi Sankyo Co Ltd Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 63. Progenics Pharmaceuticals Inc Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 64. Shionogi & Co., Ltd Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 65. Allergan Plc Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 66. Nektar Therapeutics Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 67. Purdue Pharma Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 68. S.L.A. Pharma AG Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 69. Mundipharma International Limited Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 70. Ono Pharmaceutical Co., Ltd Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 71. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 72. Theravance Biopharma Inc Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 73. Bausch Health Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 74. Cosmo Pharmaceuticals SA Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 75. Daewoong Pharmaceutical Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 76. C.B. Fleet Company Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 77. Sucampo Pharmaceuticals Revenue Growth Rate in Opioid Induced Constipation Drugs Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

---